Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00899548 · ClinicalTrials.gov registry record
DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer
A clinical trial, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Completed
- Registry status
- 182
- Enrollment target
NCT00899548: Completed study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
NCT00899548 is a clinical trial that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 182 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00899548 has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- COMPLETED
- Registry status
- 182 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood from patients with cancer and from healthy participants in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how well patients will respond to systemic therapy. PURPOSE: This laboratory study is looking at DNA in predicting response after systemic therapy in women with metastatic breast cancer.
Interventions
- GENETIC microarray analysis
- OTHER laboratory biomarker analysis
- GENETIC polymerase chain reaction
- GENETIC DNA methylation analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2007-01 |
| Est. Completion | 2016-10 |
What the finished NCT00899548 record still lists
NCT00899548 is an observational study that tracks outcomes without assigning an intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which microarray analysis is the first listed.
NCT00899548 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00899548 about?
NCT00899548 is a clinical study titled "DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer". RATIONALE: Studying samples of blood from patients with cancer and from healthy participants in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how well patients will respond to systemic therap...
What is the current status of trial NCT00899548?
This trial is currently completed. The enrollment target is 182 participants. The study started on 2007-01. Estimated completion is 2016-10.
What interventions are being tested in trial NCT00899548?
The interventions under investigation include: microarray analysis (GENETIC), laboratory biomarker analysis (OTHER), polymerase chain reaction (GENETIC), DNA methylation analysis (GENETIC).
Who is sponsoring clinical trial NCT00899548?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- NCT04323735 · 182 participants · Phase 2
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
- NCT05606731 · 182 participants · NA
Family Intervention to Prevent Childhood Obesity
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia